Marshall Wace
BCAB

Marshall Wace’s BIOATLA INC BCAB Stock Holding History

Marshall Wace’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,553
Closed -$44.4K – 3171
2026
Q1 		$44.4K Sell
5,553
-12,279
-69% -$144K ﹤0.01% 2985
2025
Q4 		$508K Buy
+17,832
New +$699K ﹤0.01% 2228
2025
Q3 		– Sell
-1,617
Closed -$32.3K – 2892
2025
Q2 		$32.3K Sell
1,617
-110
-6% -$2.23K ﹤0.01% 2621
2025
Q1 		$30.2K Sell
1,727
-5,734
-77% -$123K ﹤0.01% 2553
2024
Q4 		$220K Sell
7,461
-1,269
-15% -$107K ﹤0.01% 2328
2024
Q3 		$768K Buy
+8,730
New +$732K ﹤0.01% 1760
2024
Q1 		– Sell
-908
Closed -$112K – 2434
2023
Q4 		$112K Buy
+908
New +$78.7K ﹤0.01% 2032
2023
Q2 		– Sell
-5,713
Closed -$766K – 2470
2023
Q1 		$766K Buy
5,713
+4,945
+644% +$891K ﹤0.01% 1929
2022
Q4 		$317K Buy
+768
New +$319K ﹤0.01% 2546
2022
Q3 		– Sell
-1,091
Closed -$156K – 3338
2022
Q2 		$156K Sell
1,091
-692
-39% -$110K ﹤0.01% 3215
2022
Q1 		$445K Buy
1,783
+1,160
+186% +$485K ﹤0.01% 2826
2021
Q4 		$611K Buy
+623
New +$797K ﹤0.01% 2699

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace's BCAB Position: Q2 2026 in Review

Marshall Wace sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 5,553 shares — an estimated $44.4K sold.

Marshall Wace first reported a position in BCAB in Q4 2021 and held it in 12 quarters. The position peaked at $768K in Q3 2024. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Marshall Wace reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 5,553 BIOATLA INC shares in Q2 2026, an estimated $44.4K.
  • Marshall Wace first reported a position in BIOATLA INC in Q4 2021 and held it in 12 quarters.
  • Marshall Wace's BIOATLA INC position peaked at $768K in Q3 2024.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.